Literature DB >> 15668960

Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration.

Massimo Franceschi1, Davide Anchisi, Oriana Pelati, Marta Zuffi, Mario Matarrese, Rosa Maria Moresco, Ferruccio Fazio, Daniela Perani.   

Abstract

In patients with the frontal variant of frontotemporal lobar degeneration (fv-FTLD), behavioral abnormalities may vary from apathy with motor slowness (apathetic form) to disinhibition with agitation (disinhibited form). These clinical presentations may be related to specific regional cerebral dysfunction and to deficit in the serotoninergic system. We studied cerebral glucose uptake using (18)F-fluorodeoxyglucose and positron emission tomography in 18 patients fulfilling clinical criteria for fv-FTLD and showing, respectively, an apathetic or disinhibited behavioral syndrome. In eight of these patients, we also evaluated the 5-hydroxytryptamine-2A receptor cerebral receptor distribution with [(11)C]MDL and positron emission tomography. We found a reduction of frontal glucose metabolism in the whole group of fv-FTLD patients. Apathetic syndrome was associated with a prevalent dorsolateral and frontal medial hypometabolism, whereas the disinhibited syndrome demonstrated a selective hypometabolism in interconnected limbic structures (the cingulate cortex, hippocampus/amygdala, and accumbens nucleus). The in vivo measurements of [(11)C]MDL indicated a significant reduction of 5-hydroxytryptamine-2A receptors in orbitofrontal, frontal medial, and cingulate cortices. These (18)F-fluorodeoxyglucose positron emission tomography changes can be considered as specific functional markers of the different behavioral presentations in fv-FTLD. The serotoninergic system dysfunction provides a rationale for therapeutic trials with selective serotonin reuptake inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668960     DOI: 10.1002/ana.20365

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  50 in total

1.  A tensor based morphometry study of longitudinal gray matter contraction in FTD.

Authors:  Simona M Brambati; Natasha C Renda; Katherine P Rankin; Howard J Rosen; William W Seeley; John Ashburner; Michael W Weiner; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  Neuroimage       Date:  2007-02-04       Impact factor: 6.556

2.  Apathy and disinhibition in frontotemporal dementia: Insights into their neural correlates.

Authors:  G Zamboni; E D Huey; F Krueger; P F Nichelli; J Grafman
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

Review 3.  PET/CT in diagnosis of dementia.

Authors:  Valentina Berti; Alberto Pupi; Lisa Mosconi
Journal:  Ann N Y Acad Sci       Date:  2011-06       Impact factor: 5.691

4.  MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes.

Authors:  Yu Zhang; Maria Carmela Tartaglia; Norbert Schuff; Gloria C Chiang; Christopher Ching; Howard J Rosen; Maria Luisa Gorno-Tempini; Bruce L Miller; Michael W Weiner
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 5.  Serotonergic system, cognition, and BPSD in Alzheimer's disease.

Authors:  Saikat Chakraborty; Jack C Lennon; Sridhar A Malkaram; Yan Zeng; Daniel W Fisher; Hongxin Dong
Journal:  Neurosci Lett       Date:  2019-04-01       Impact factor: 3.046

6.  Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease.

Authors:  Tommaso Ballarini; Leonardo Iaccarino; Giuseppe Magnani; Nagehan Ayakta; Bruce L Miller; William J Jagust; Maria Luisa Gorno-Tempini; Gil D Rabinovici; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2016-07-13       Impact factor: 5.038

Review 7.  New potential therapeutic approaches in frontotemporal dementia: oxytocin, vasopressin, and social cognition.

Authors:  Elizabeth C Finger
Journal:  J Mol Neurosci       Date:  2011-05-27       Impact factor: 3.444

Review 8.  Therapy and clinical trials in frontotemporal dementia: past, present, and future.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

Review 9.  Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Authors:  Gil D Rabinovici; Bruce L Miller
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 10.  Selective functional, regional, and neuronal vulnerability in frontotemporal dementia.

Authors:  William W Seeley
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.